Stock Screener App

無料 -

インストール

45.68

8.20% 3.46

Spyre Therapeutics Inc (SYRE)

概要ニュース株価時系列 Financials ディスカッション予測

Spyre Therapeutics Inc (SYRE) 財務データ

*すべての数値は百万単位です

期間終了日	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	-	-
Operating Expenses	0.50% 57.17	56.89	41.94	53.57	55.39
Operating Income/Loss	0.50% -57.17	-56.89	-41.94	-53.57	-55.39
Nonoperating Income/Loss	111.72% -5.358	45.70	5.218	8.779	-13.62
Income/Loss From Continuing Operations Before Tax	459.15% -62.53	-11.18	-36.72	-44.79	-69.01
Income Tax Expense/Benefit	-	-	-	-0.015	0.018
Income/Loss From Continuing Operations After Tax	459.15% -62.53	-11.18	-36.72	-44.77	-69.03
Net Income/Loss	459.15% -62.53	-11.18	-36.72	-44.77	-69.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く